121 related articles for article (PubMed ID: 17015253)
1. Modulation of transcription factor NF-kappaB in Hodgkin's lymphoma cell lines: effect of (-)-epicatechin.
Mackenzie GG; Oteiza PI
Free Radic Res; 2006 Oct; 40(10):1086-94. PubMed ID: 17015253
[TBL] [Abstract][Full Text] [Related]
2. Dimeric procyanidin B2 inhibits constitutively active NF-kappaB in Hodgkin's lymphoma cells independently of the presence of IkappaB mutations.
Mackenzie GG; Adamo AM; Decker NP; Oteiza PI
Biochem Pharmacol; 2008 Apr; 75(7):1461-71. PubMed ID: 18275936
[TBL] [Abstract][Full Text] [Related]
3. Epicatechin, catechin, and dimeric procyanidins inhibit PMA-induced NF-kappaB activation at multiple steps in Jurkat T cells.
Mackenzie GG; Carrasquedo F; Delfino JM; Keen CL; Fraga CG; Oteiza PI
FASEB J; 2004 Jan; 18(1):167-9. PubMed ID: 14630700
[TBL] [Abstract][Full Text] [Related]
4. Characterization of NF-kappaB expression in Hodgkin's disease: inhibition of constitutively expressed NF-kappaB results in spontaneous caspase-independent apoptosis in Hodgkin and Reed-Sternberg cells.
Izban KF; Ergin M; Huang Q; Qin JZ; Martinez RL; Schnitzer B; Ni H; Nickoloff BJ; Alkan S
Mod Pathol; 2001 Apr; 14(4):297-310. PubMed ID: 11301346
[TBL] [Abstract][Full Text] [Related]
5. Benzisothiazolone Derivatives Exhibit Cytotoxicity in Hodgkin's Lymphoma Cells through NF-κB Inhibition and are Synergistic with Doxorubicin and Etoposide.
Nandakumar N; Gopinath P; Gopas J; Muraleedharan KM
Anticancer Agents Med Chem; 2020; 20(6):715-723. PubMed ID: 32053083
[TBL] [Abstract][Full Text] [Related]
6. CD30-induced signaling is absent in Hodgkin's cells but present in anaplastic large cell lymphoma cells.
Hirsch B; Hummel M; Bentink S; Fouladi F; Spang R; Zollinger R; Stein H; Dürkop H
Am J Pathol; 2008 Feb; 172(2):510-20. PubMed ID: 18187570
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the genes coding for the NF-κB regulating factors IκBα and A20 are uncommon in nodular lymphocyte-predominant Hodgkin's lymphoma.
Schumacher MA; Schmitz R; Brune V; Tiacci E; Döring C; Hansmann ML; Siebert R; Küppers R
Haematologica; 2010 Jan; 95(1):153-7. PubMed ID: 19648161
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignancies.
Thomas RK; Sos ML; Zander T; Mani O; Popov A; Berenbrinker D; Smola-Hess S; Schultze JL; Wolf J
Clin Cancer Res; 2005 Nov; 11(22):8186-94. PubMed ID: 16299251
[TBL] [Abstract][Full Text] [Related]
9. Defective IkappaBalpha in Hodgkin cell lines with constitutively active NF-kappaB.
Wood KM; Roff M; Hay RT
Oncogene; 1998 Apr; 16(16):2131-9. PubMed ID: 9572494
[TBL] [Abstract][Full Text] [Related]
10. Nuclear factor kappaB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity.
Hinz M; Lemke P; Anagnostopoulos I; Hacker C; Krappmann D; Mathas S; Dörken B; Zenke M; Stein H; Scheidereit C
J Exp Med; 2002 Sep; 196(5):605-17. PubMed ID: 12208876
[TBL] [Abstract][Full Text] [Related]
11. TRAF1 is involved in the classical NF-kappaB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells.
Guo F; Sun A; Wang W; He J; Hou J; Zhou P; Chen Z
Mol Immunol; 2009 Aug; 46(13):2441-8. PubMed ID: 19540595
[TBL] [Abstract][Full Text] [Related]
12. Heat shock protein 90 inhibitor BIIB021 (CNF2024) depletes NF-kappaB and sensitizes Hodgkin's lymphoma cells for natural killer cell-mediated cytotoxicity.
Böll B; Eltaib F; Reiners KS; von Tresckow B; Tawadros S; Simhadri VR; Burrows FJ; Lundgren K; Hansen HP; Engert A; von Strandmann EP
Clin Cancer Res; 2009 Aug; 15(16):5108-16. PubMed ID: 19671844
[TBL] [Abstract][Full Text] [Related]
13. Nuclear transcription factor-kappaB in Hodgkin's disease.
Younes A; Garg A; Aggarwal BB
Leuk Lymphoma; 2003 Jun; 44(6):929-35. PubMed ID: 12854890
[TBL] [Abstract][Full Text] [Related]
14. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.
Bargou RC; Emmerich F; Krappmann D; Bommert K; Mapara MY; Arnold W; Royer HD; Grinstein E; Greiner A; Scheidereit C; Dörken B
J Clin Invest; 1997 Dec; 100(12):2961-9. PubMed ID: 9399941
[TBL] [Abstract][Full Text] [Related]
15. (-)-Epicatechin in the prevention of tumor necrosis alpha-induced loss of Caco-2 cell barrier integrity.
Contreras TC; Ricciardi E; Cremonini E; Oteiza PI
Arch Biochem Biophys; 2015 May; 573():84-91. PubMed ID: 25795020
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of canonical NF-κB nuclear localization by (-)-DHMEQ via impairment of DNA binding.
Horie K; Ma J; Umezawa K
Oncol Res; 2015; 22(2):105-15. PubMed ID: 25706397
[TBL] [Abstract][Full Text] [Related]
17. NF-kappaB is involved in the survival of cerebellar granule neurons: association of IkappaBbeta [correction of Ikappabeta] phosphorylation with cell survival.
Koulich E; Nguyen T; Johnson K; Giardina C; D'mello S
J Neurochem; 2001 Feb; 76(4):1188-98. PubMed ID: 11181838
[TBL] [Abstract][Full Text] [Related]
18. Quorum sensing modulators exhibit cytotoxicity in Hodgkin's lymphoma cells and interfere with NF-κB signaling.
Nandakumar N; Dandela R; Gopas J; Meijler MM
Bioorg Med Chem Lett; 2017 Jul; 27(13):2967-2973. PubMed ID: 28526369
[TBL] [Abstract][Full Text] [Related]
19. CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-kappaB activation.
Lenert P; Stunz L; YI AK; Krieg AM; Ashman RF
Antisense Nucleic Acid Drug Dev; 2001 Aug; 11(4):247-56. PubMed ID: 11572601
[TBL] [Abstract][Full Text] [Related]
20. Curcumin induces cell-arrest and apoptosis in association with the inhibition of constitutively active NF-kappaB and STAT3 pathways in Hodgkin's lymphoma cells.
Mackenzie GG; Queisser N; Wolfson ML; Fraga CG; Adamo AM; Oteiza PI
Int J Cancer; 2008 Jul; 123(1):56-65. PubMed ID: 18386790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
